News
Where Will Kraft Heinz Find Revenue Growth Going Forward?
Kraft Heinz (NASDAQ: KHC) has demonstrated that it can cut costs (to the tune of nearly $2 billion) thanks to the playbook of major shareholder 3G Capital. But what about top line expansion? In....
You'll Be Stunned by How Many Cancer Immunotherapies Are Being Developed
For years, chemotherapy was the best treatment that the world of medicine had to offer in fighting cancer. That's no longer true. A powerful new class of cancer drugs called immunotherapies has....
Why 2017 Was a Year to Remember for Microsoft Corporation
Microsoft's (NASDAQ: MSFT) had a lot to write home about this past year. The company beat analysts' consensus earnings estimates four times in 2017, made huge strides toward its lofty cloud....
2 Tech Companies With Enormous Free Cash Flow
In investing, free cash flow is the good stuff. Defined as a company's cash from operations minus its capital expenditures, free cash flow is the cold, hard cash left over after regular operations....
Can Blue Apron Stock Keep Going After Last Week's 19% Pop?
One of this year's worst IPOs was one of last week's biggest winners. Shares of Blue Apron (NYSE: APRN) rose 18.9% for the week, moving higher on an analyst upgrade following the news near the end....
3 Things You Can Do to Land a Job in 2018
Whether you're a recent college graduate or a seasoned employee in between jobs, finding work can be a challenge -- especially around this time of year, when hiring tends to slow down and key....
Inside SpaceX: What It’s Like Working for a Company on a Mission to Mars
When you learn that SpaceX's mission is to make humans multi-planetary, it might sound kind of crazy. But, as Vice President of Human Resources at SpaceX Brian Bjelde points out, people used to....
What Is the Obamacare "Death Spiral" -- and Can It Be Stopped?
Since before the Affordable Care Act was signed into law, a vocal group of Republican opponents have been warning that Obamacare would destabilize the private insurance markets. One of their....
Will Defense Stocks Soar on Trump's $683 Billion Budget Boost?
The Congressional Budget Office (CBO) has laid out the bull case for defense stocks, concluding in a report that the full military buildup advocated by the Trump Administration would boost....
Starbucks Opens Its Second Roastery as It Aims to Move Upmarket
Earlier this week, Starbucks (NASDAQ: SBUX) opened its second Starbucks Reserve Roastery. The pilot location opened in Starbucks' hometown of Seattle three years ago. Fittingly, the second....
This Marijuana Stock CEO Recently Revealed His Plans to The Motley Fool
Canopy Growth Corp. (NASDAQOTH: TWMJF) is the largest pure-play cannabis company on the market. It operates in six countries, but it gets the lion's share of its sales from serving Canada's....
Will the GOP Tax Plan Lead to a Surge in Marijuana Legalizations?
There's a reason the legal marijuana industry is known as the "green rush." According to a report from Marijuana Business Daily, entitled "Marijuana Business Factbook 2017," the U.S. legal....
3 Top Pipeline Stocks to Buy Now
There are more than 2.4 million miles of energy pipelines running through the United States, which is the largest network of oil and gas pipes in the world. This system ensures that there's enough....
Is Gilead Sciences, Inc. a Buy?
With only a few weeks remaining in 2017, Gilead Sciences (NASDAQ: GILD) stock price appears to be on course to finish roughly at the same level that it began the year. After getting off to a rocky....
Why Opko Health Stock Stumbled in November
Shares of Opko Health (NASDAQ: OPK) had another poor showing in November, with its stock shedding a whopping 19.5% of its value last month, according to data from S&P Global Market....
What This Apple Supplier Just Told Us About iPhone X Demand
For quite a while, chipmaker Broadcom (NASDAQ: AVGO) has telegraphed to the investment community that it expects to see a substantial boost in the dollar content within Apple's (NASDAQ: AAPL) 2017....
3 Growth Stocks I'd Buy Right Now
What's a six-letter word that's guaranteed to make investors happy? Growth. While growth comes in several flavors, they're all interrelated. Growth in revenue helps make earnings growth possible,....
What You Don't Know About Social Security in 2018
Social Security is a vital part of the financial planning strategy for tens of millions of Americans, and between the retirement and disability benefits it pays to workers and the host of family....
Why Celldex Therapeutics Stock Reversed Course in November
Shares of the struggling small-cap biotech Celldex Therapeutics (NASDAQ: CLDX) finally showed some signs of life in November. Specifically, the biotech's stock rose by a healthy 27.6% last....
Forget Bitcoin: IOTA Just Partnered With 5 Brand-Name Companies on a New Project
We're just three weeks from turning the calendar on 2017, but cryptocurrency price appreciation has shown absolutely no signs of slowing. While marijuana and cloud-computing stocks have impressed,....
More Marijuana Stock Deal-Making Is on the Way for This 1 Simple Reason
Canopy Growth (NASDAQOTH: TWMJF) rocked the cannabis industry in October when it announced a $245 million deal with Constellation Brands (NYSE: STZ), the maker of Corona beer and a long lineup of....
Better Buy: Pfizer (PFE) vs. AbbVie (ABBV)
For Pfizer (NYSE: PFE), 2017 so far has looked better than the past couple of years in terms of stock performance. However, the stock's 9% year-to-date gain isn't anything to jump up and down....
In Your 40s? 2 Stocks You Might Want to Buy
If you are in your 40s, you're still building a nest egg... and likely dealing with the responsibilities that come along with a family and home. You aren't yet looking for dividend income, but you....
5 Financial Resolutions for the New Year
With 2018 almost upon us, now's the time to embrace a seemingly timeless trend: the New Year's resolution. Each year, countless Americans pledge to do better in all aspects of their lives, money....
Is Now the Perfect Time to Buy Juno Therapeutics Stock?
Juno Therapeutics (NASDAQ: JUNO), a clinical-stage oncology company, continued its unrelenting rally this year by tacking on another $5 billion to its market cap in November, according to data....